Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea

A legfontosabb adatok

Ki végzi
Inspire Medical Systems, Inc.
Hol
Atlanta, Boston, Cincinnati, Dallas, Madison, Norfolk, Philadelphia és Pittsburgh (Egyesült Államok)Mind a 8 helyszín megnézése
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
57 fő vett részt
Kezdés
2021. jún. 24.
Befejezés
2026. szept. 30.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Inspire Upper Airway Stimulation (UAS) System
A regiszteradat frissítve
2026. augusztus 25.

Ki vehet részt

Életkor
10 év – 21 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 23 feltétel megnézéseKevesebb

Ki vehet részt

  • Diagnosis of Down syndrome
  • Age 10-21 years
  • Prior adenotonsillectomy
  • Severe OSA (AHI > 10, AHI < 50, no more than 25% AHI attributable to central events) based on prior in-lab PSG performed after adenotonsillectomy and within 18 months of enrollment
  • Approval from at least two of the three physician reviewers based upon the results of a routine drug-induced sleep endoscopy (DISE) having occurred within 12 months of enrollment
  • Subjects must have either tracheotomy or be ineffectively treated with CPAP due to non-compliance, discomfort, un-desirable side effects, persistent symptoms despite compliance use, or refusal to use the device
  • Children and their parents/guardians must be willing to have stimulation hardware permanently implanted, and be willing to participate in follow-up visits, postoperative PSG, and questionnaire completion
  • Children's parents/guardians must complete a questionnaire confirming that their child is capable of communicating feelings of pain or discomfort. They must also confirm they are able to assess their child for adverse effects related to device implantation
  • Children and their parents/guardians must be proficient in English

Ki nem vehet részt

  • History of bleeding or clotting disorders and those on blood thinning or NSAID medications for the week prior to implantation surgery. Subjects will be asked to refrain from the use of NSAIDS for two weeks after implantation or any revision surgeries
  • Subject is currently taking muscle relaxant medication
  • Other medical conditions resulting in medical instability (eg. congestive heart failure, recent open heart surgery, immunosuppression, or chronic lung disease or aspiration)
  • Presence of another medical condition requiring future magnetic resonance imaging (MRI) of the chest
  • Subjects with a co-occurring diagnosis of autism spectrum disorder
  • Body mass index (BMI) above the 95th percentile for subject's age
  • Circumferential airway collapse at the level of the velopharynx observed during DISE
  • Patients with another implantable device which could interact unintentionally with the Inspire system
  • Any contraindication for general anesthesia
  • Life expectancy less than 12 months
  • Subject's inability to communicate pain or discomfort to their caretaker/parent, based on parental or investigator assessment
  • Nonverbal candidates will be excluded due to an inability to complete testing procedures including expressive language sampling
  • Subjects that have a positive β-HCG
  • Subjects deemed unfit for participation by the investigator for any other reason

Helyszínek itt: Egyesült Államok

  • Children's Healthcare of Atlanta/Emory University School of MedicineAtlanta, Egyesült Államok
  • Massachusetts General Hospital (Mass Eye & Ear Infirmary)Boston, Egyesült Államok
  • Cincinnati Childrens HospitalCincinnati, Egyesült Államok
  • University of Texas Southwestern/Children's Hospital of DallasDallas, Egyesült Államok
  • University of Wisconsin School of Medicine and Public HealthMadison, Egyesült Államok
  • Children's Hospital of the King's Daughters/East Virginia Medical SchoolNorfolk, Egyesült Államok
  • Children's Hospital of PhiladelphiaPhiladelphia, Egyesült Államok
  • Children's Hospital of PittsburghPittsburgh, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This study is a prospective, single-arm study conducted under a common implant and follow-up protocol. The objective will be to follow fifty-seven (57) adolescents and young adults (10-21 years of age), with Down syndrome, moderate to severe sleep apnea, and post-adenotonsillectomy, for 12 months after undergoing implant of the Inspire Upper Airway Stimulation (UAS) System. The study is being conducted in order to evaluate objective change in cognition and expressive language after implant and therapy with the Inspire UAS System.

A vizsgálat csoportja

  • Subjects implanted with Inspire UAS SystemA vizsgált kezelés

    Subjects who meet eligibility criteria will be implanted with the Inspire Upper Airway Stimulation (UAS) System.

    Kezelés: Inspire Upper Airway Stimulation (UAS) System

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. augusztus 25.